Skip to main content


Special issue 2024 about "Drug-induced diseases" coordinated by Haleh Bagheri, is available on line.


We would like to thank Haleh Bagheri and the authors who contributed to the quality of this issue




Drug-induced diseases: A worrying, neglected, preventable, serious and costly epidemic

Jean-Louis Montastruc


Patient's reporting of adverse drug reactions: Which added value in 2023?

Haleh Bagheri


Drug-induced cardiac toxicity and adverse drug reactions, a narrative review

Alexandre Destere, Diane Merino, Thibaud Lavrut, Fanny Rocher, Delphine Viard, Milou-Daniel Drici, Alexandre O. Gérard


Drug-induced psychiatric disorders: A pharmacovigilance update

François Montastruc, Tanguy Taillefer de Laportaliere


Antibiotic-induced neurological adverse drug reactions

Clémence Lacroix, Tessa Pietri, Vincent Montero, Thomas Soeiro, Frank Rouby, Olivier Blin, Romain Guilhaumou, Joëlle Micallef


Drug-induced tumoral disease: A global pharmacovigilance database analysis

Yoann Zelmat, Fabien Despas


Adverse drug reactions on male fertility

Isabelle Lacroix


Drug-induced fetal and offspring disorders, beyond birth defects

Margaux Louchet, Mylène Tisseyre, Florentia Kaguelidou, Jean-Marc Treluyer, Laure-Hélène Préta, Laurent Chouchana


Drug-induced hyperglycemia and diabetes

Marie-Anne Heurtebize, Jean-Luc Faillie


Cutaneous adverse drug reactions

Thomas Bettuzzi, Paola Sanchez-Pena, Bénédicte Lebrun-Vignes


Drug-induced glomerular diseases

Anne-Sophie Garnier, Hélène Laubacher, Marie Briet


Drug-induced hearing loss: Listening to the latest advances

Pierre Reynard, Hung Thai-Van

  • Dernière mise à jour le .